Kevin Starr

Kevin Starr is a proven operational leader with over 25 years’ experience building and operating leading biotech companies. Mr. Starr co-founded Third Rock Ventures in 2007 and focuses on the formation, development and business strategy of its portfolio companies as well as actively identifying and evaluating new investments. He also assumes active leadership roles in Third Rock portfolio companies. Prior to Third Rock Ventures, Mr. Starr was chief operating officer and chief financial officer at Millennium Pharmaceuticals, where he led efforts to raise billions of dollars in capital through strategic alliances and public financing and drove growth through company expansion and mergers and acquisitions. Earlier in his career, he served in various executive roles at Millennium BioTherapeutics, Biogen and Digital Equipment Corporation. Mr. Starr holds a master of science in corporate finance from Boston College and a bachelor of arts in mathematics and business from Colby College. He is a board member of Alnylam Pharmaceuticals and also serves on the board of directors for Afferent Pharmaceuticals, Agios Pharmaceuticals and Zafgen, Inc.